Daniel J. Morath, Ph.D.

Shareholder

Dr. Morath, a Shareholder, holds a Ph.D. in Molecular Biology from the University of Utah, a B.S. in Cellular and Molecular Biology from the University of Michigan, and a J.D. from Brigham Young University.

Dr. Morath’s doctoral dissertation was centered around the development of glial stem cells, and specifically on the metal requirements for proper fate specification and differentiation. As a post-doctoral fellow, Dr. Morath staged the embryonic lethality of Anitizyme 1/2 knockout mice, generated novel myoblast cell lines and explored the effects of gentamicin treatment on stop codon readthrough.

superlawyer-morath

Professional Recognition

  • Super Lawyers Rising Stars – 2009-2010

Areas of Special Expertise

  • Infringement, validity and enforceability evaluations
  • Molecular biology, cell biology, immunology, genetics
  • Pharmaceuticals, cosmetics
  • Technology evaluation and invention identification

Technical Expertise

  • Biotechnology

Prior Professional Experience

  • Post doctoral fellow, Gesteland lab, University of Utah

Education

  • University of Michigan, B.S. in Cellular & Molecular Biology
  • University of Utah, Ph.D. in Molecular Biology
  • Brigham Young University, Juris Doctor

Bar Admissions

  • U.S. Patent and Trademark Office
  • Utah Bar

Publications and Presentations

  • Morath, Groves, Noble, and Mayer-Pröschel. “Characterization of immortalized neuroepithelial stem cells.” Abstract, 36th American Society for Cell Biology Annual Meeting (1996).
  • Morath and Mayer-Pröschel. “Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes.” Developmental Biology 237(1) (2001): 232-43.
  • Mayer-Pröschel, Morath, and Noble. “Are hypothyroidism and iron deficiency precursor cell diseases?” Developmental Neuroscience 23(4-5) (2001):277-86.
  • Morath and Mayer-Pröschel. “Iron Deficiency during embryogenesis and consequences for oligodendrocyte generation in vivo.” Developmental Neuroscience 24(2-3) (2002):197-207.

Community and Professional Organizations

  • Member, Phi Lambda Upsilon, National Honorary Chemical Society
  • Member, Provider Human Rights Committee, Achieve Community Services